231 related articles for article (PubMed ID: 22727770)
21. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
22. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
[TBL] [Abstract][Full Text] [Related]
23. Intravenous colistin administration in neonates.
Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
[TBL] [Abstract][Full Text] [Related]
24. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.
Linden PK; Paterson DL
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S89-94. PubMed ID: 16894521
[TBL] [Abstract][Full Text] [Related]
25. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.
Rios FG; Luna CM; Maskin B; Saenz Valiente A; Lloria M; Gando S; Sosa C; Baquero S; Llerena C; Petrati C; Apezteguia C
Eur Respir J; 2007 Aug; 30(2):307-13. PubMed ID: 17504791
[TBL] [Abstract][Full Text] [Related]
26. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
27. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
[TBL] [Abstract][Full Text] [Related]
28. Colistin: an update on the antibiotic of the 21st century.
Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit.
İşgüder R; Ağın H; Ceylan G; Bayram N; Devrim İ
Am J Infect Control; 2016 Jun; 44(6):734-5. PubMed ID: 26921012
[No Abstract] [Full Text] [Related]
31. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.
Celik IH; Oguz SS; Demirel G; Erdeve O; Dilmen U
Eur J Pediatr; 2012 Feb; 171(2):311-6. PubMed ID: 21809011
[TBL] [Abstract][Full Text] [Related]
32. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
33. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.
Sánchez A; Gattarello S; Rello J
Semin Respir Crit Care Med; 2011 Apr; 32(2):151-8. PubMed ID: 21506051
[TBL] [Abstract][Full Text] [Related]
34. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
Dimitriades K; Morrow BM; Jeena P
Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
[TBL] [Abstract][Full Text] [Related]
36. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
[TBL] [Abstract][Full Text] [Related]
37. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
38. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
[TBL] [Abstract][Full Text] [Related]
39. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
Motaouakkil S; Charra B; Hachimi A; Benslama A
Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
[No Abstract] [Full Text] [Related]
40. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
